The Role of Regulatory Non-Coding RNA in Cancer

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".

Deadline for manuscript submissions: closed (28 February 2025) | Viewed by 2001

Special Issue Editors


E-Mail Website
Guest Editor
Tumor Biology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, USA
Interests: tumor biology; melanoma; skin cancers; photobiology; photochemistry
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Tumor Biology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, USA
Interests: melanoma; melanin biochemistry; skin pigmentation; melanin chemiexcitation; human genetics; environmental carcinogenicity
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Although initially presumed to be non-functional, numerous studies in the past decade have established the indispensable functions of non-coding RNAs (ncRNAs), including in chromatin remodeling and transcriptional and post-transcriptional regulation. In cancer, some types of ncRNA have been implicated in events of initiation and progression. These include microRNAs (miRNAs), long non-coding RNAs (lncRNAs), small interfering RNAs (siRNAs), PIWI-interacting RNAs, small nucleolar RNAs (snoRNAs), and sno-derived RNAs. Most studies discuss the involvement of miRNAs, siRNAs, and lncRNAs in different cancers, but other ncRNA types are also supposed to make significant contributions to carcinogenesis.

Since ncRNAs are critical in cancer development and metastasis, this Special Issue will not only describe the novel ncRNAs but also the unexplored mechanisms by which these ncRNAs regulate distinct aspects of carcinogenesis. This Special Issue will also focus on the therapeutic targeting of these ncRNAs in order to develop and optimize anticancer strategies. Moreover, this Special Issue will discuss whether the specific ncRNAs have tissue and/or cancer type-specific roles and regulation.

Dr. Jyoti Srivastava
Dr. Sanjay Premi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer initiation
  • cancer progression
  • metastasis
  • ncRNAs
  • miRNAs
  • lncRNAs
  • gene regulation
  • chromatin remodeling
  • targeted therapeutics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

41 pages, 2230 KiB  
Review
Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application
by Éva Márton, Alexandra Varga, Dóra Domoszlai, Gergely Buglyó, Anita Balázs, András Penyige, István Balogh, Bálint Nagy and Melinda Szilágyi
Cancers 2025, 17(4), 579; https://doi.org/10.3390/cancers17040579 - 8 Feb 2025
Cited by 1 | Viewed by 1604
Abstract
We are on the brink of a paradigm shift in both theoretical and clinical oncology. Genomic and transcriptomic profiling, alongside personalized approaches that account for individual patient variability, are increasingly shaping discourse. Discussions on the future of personalized cancer medicine are mainly dominated [...] Read more.
We are on the brink of a paradigm shift in both theoretical and clinical oncology. Genomic and transcriptomic profiling, alongside personalized approaches that account for individual patient variability, are increasingly shaping discourse. Discussions on the future of personalized cancer medicine are mainly dominated by the potential of non-coding RNAs (ncRNAs), which play a prominent role in cancer progression and metastasis formation by regulating the expression of oncogenic or tumor suppressor proteins at transcriptional and post-transcriptional levels; furthermore, their cell-free counterparts might be involved in intercellular communication. Non-coding RNAs are considered to be promising biomarker candidates for early diagnosis of cancer as well as potential therapeutic agents. This review aims to provide clarity amidst the vast body of literature by focusing on diverse species of ncRNAs, exploring the structure, origin, function, and potential clinical applications of miRNAs, siRNAs, lncRNAs, circRNAs, snRNAs, snoRNAs, eRNAs, paRNAs, YRNAs, vtRNAs, and piRNAs. We discuss molecular methods used for their detection or functional studies both in vitro and in vivo. We also address the challenges that must be overcome to enter a new era of cancer diagnosis and therapy that will reshape the future of oncology. Full article
(This article belongs to the Special Issue The Role of Regulatory Non-Coding RNA in Cancer)
Show Figures

Figure 1

Back to TopTop